This inventor holds 1 USPTO granted patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Nih Division of Extramural Inventions and Technology Resources (Deitr), Tsrl, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,696 
1 out of 1 
1 out of 7 Years Active: 2011
Title: The Ingenious Mind of Kanokkarn Saejueng: Innovator in Prodrug Chemistry
Introduction: Kanokkarn Saejueng is a noteworthy inventor based in Los Angeles, CA. With a passion for medicinal chemistry, she has made significant contributions to the field through her innovative work on prodrugs.
Latest Patents: Kanokkarn holds a patent for "Phosphonyl ester conjugates as prodrugs," which focuses on Cidofovir or foscarnet-based compounds. These compounds include amino acid or dipeptide esters that function as prodrugs, demonstrating her expertise in the development of pharmaceutical innovations aimed at improving drug efficacy.
Career Highlights: Throughout her career, Kanokkarn has worked at prominent organizations such as Tsrl, Inc. and the National Institutes of Health (NIH). Her experience in these prestigious institutions has enhanced her proficiency in drug development and biotechnology, paving the way for her groundbreaking inventions.
Collaborations: Kanokkarn has collaborated with esteemed professionals in her field, including John Hilfinger and Charles E. McKenna. These partnerships have not only expanded her network but also contributed to the advancement of her research initiatives.
Conclusion: Kanokkarn Saejueng stands out as a remarkable inventor whose contributions to prodrug chemistry have the potential to improve therapeutic outcomes for various medical conditions. Her ongoing work and collaborations emphasize the importance of innovation in the pharmaceutical industry, marking her as a key player in the future of drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile